Sam Cooper founded Phenomic AI in 2017 alongside Oren Kraus, as an early stage biotech company seeking to commercialise AI approaches for pharmaceutical R&D. He discusses the role of AI in drug discovery with Lu Rahman. LR: Where are we with deep learning and drug discovery and how effective is it for researchers? How well […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!